CD44 inhibition attenuates EGFR signaling and enhances cisplatin sensitivity in human EGFR wild‑type non‑small‑cell lung cancer cells-Reference-Cited by-同舟云学术

CD44 inhibition attenuates EGFR signaling and enhances cisplatin sensitivity in human EGFR wild‑type non‑small‑cell lung cancer cells

Published:2020-04-01 Issue: Volume: Page:
ISSN:1107-3756
Container-title:International Journal of Molecular Medicine
language:
Short-container-title:Int J Mol Med

Author:

Yin Jianhua¹,Zhang Hanyu¹,Wu Xu¹,Zhang Yuchen²,Li Jing³,Shen Jing¹,Zhao Yueshui¹,Xiao Zhangang¹,Lu Lan⁴,Huang Chengliang⁵,Zhang Zhuo¹,Du Fukuan¹,Wu Yuanlin¹,Kaboli Parham¹,Cho Chi¹,Yuan Dandan⁶,Li Mingxing¹

Affiliation:

1. Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China

2. Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Hong Kong, SAR 999077, P.R. China

3. Department of Oncology and Hematology, Hospital (T.C.M) Affiliated to Southwest Medical University, Luzhou, Sichuan 646000, P.R. China

4. Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu, Sichuan 610000, P.R. China

5. Department of Respiratory and Critical Care Medicine II, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P.R. China

6. Department of Internal Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 250000, P.R. China

Publisher

Spandidos Publications

Subject

Genetics,General Medicine

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging paradigms and recent progress in targeting ErbB in cancers;Trends in Pharmacological Sciences;2024-06

2. CD44 and its implication in neoplastic diseases;MedComm;2024-05-23

3. CD44: A New Prognostic Marker in Colorectal Cancer?;Cancers;2024-04-19

4. N‐allyl quinoxaline derivative exhibited potent and selective cytotoxicity through EGFR/VEGFR‐mediated apoptosis: In vitro and in vivo studies;Journal of Biochemical and Molecular Toxicology;2024-03-16

5. miR-204 suppresses cancer stemness and enhances osimertinib sensitivity in non-small cell lung cancer by targeting CD44;Molecular Therapy - Nucleic Acids;2024-03